Patent details

Basic Information

Publication number:

EP3181567

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP171528987

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS

French Title of Invention:

COMPOSÉS DE PYRAZOLOPYRIMIDINE EN TANT QU'INHIBITEURS DE KINASE

German Title of Invention:

PYRAZOLOPYRIMIDINVERBINDUNGEN ALS KINASEINHIBITOREN

SPC Number:

Dates

Filing date:

06/09/2013

Grant date:

20/03/2019

EP Publication Date:

21/06/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/03/2019

EP B1 Publication Date:

20/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/09/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/12/2025

 

 

Name:

PRINCIPIA BIOPHARMA INC.

Address:

100 Morris Street,, 07960, Morristown, New Jersey, United States (US)

History of Owners

From:

17/05/2019

To:

04/12/2025

Name:

Principia Biopharma Inc.

Address:

220 E. Grand Ave., S. San Francisco, CA 94080, United States (US)

From:

13/03/2019

To:

17/05/2019

Name:

Principia Biopharma Inc.

Address:

200 E. Grand Ave., S. San Francisco, CA 94080, United States (US)

Agent

1

Name:

NLO

From:

14/01/2026

Address:

P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)

To:

2

Name:

ARONOVA S.A.

From:

31/05/2019

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

08/01/2026

Inventor

1

Name:

Verner, Erik

Address:

United States (US)

2

Name:

Owens, Tim

Address:

United States (US)

Priority

1

Priority Number:

201261699038 P

Priority Date:

10/09/2012

Priority Country:

United States (US)

2

Priority Number:

201261728693 P

Priority Date:

20/11/2012

Priority Country:

United States (US)

3

Priority Number:

201361782605 P

Priority Date:

14/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/519; A61P 29/00; A61P 35/00; A61P 37/00; C07D 487/04; C07D 519/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2026/01

Publication date:

05/01/2026

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201912

Publication date:

20/03/2019

Description:

Grant (B1)

2

Issue number:

202539

Publication date:

24/09/2025

Description:

Document reprinted after correction (B8, B9)

3

Issue number:

201925

Publication date:

19/06/2019

Description:

Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000457A

Date Registered:

04/12/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

IPSILON LUXEMBOURG S.A.

Journal Edition Number:

Text:

Change of address

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

PRINCIPIA BIOPHARMA INC.

Address:

100 Morris Street,, 07960, Morristown, New Jersey, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2026

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

29/08/2025

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
07/06/2019	Outgoing Correspondence	1
31/05/2019	Power Of Attorney	1
16/10/2025	Power Of Attorney	1
17/11/2025	Power Of Attorney	1
04/12/2025	Power Of Attorney	1
04/12/2025	Request For Change	1
05/12/2025	Outgoing Correspondence	1
08/01/2026	Request For Change	1
08/01/2026	Outgoing Correspondence	1
14/01/2026	Outgoing Correspondence	1
13/01/2026	Power Of Attorney	1